Walid M. Awni,Menon Rajeev M.,Wei Liu,Dutta Sandeep,Barry M. Bernstein,Thomas J. Podsadecki,Andrew L. Campbell,Lin Chih-Wei,Wang Tianli
申请号：
NZ71913714
公开号：
NZ719137A
申请日:
2014.03.14
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
Disclosed is a method for treatment for HCV, comprising administering at least two direct acting antiviral agents (DAAs) to an HCV patient, wherein neither interferon nor ribavirin are administered to said patient during said treatment, and said treatment lasts for 8, 9, 10, 11 or 12 weeks, and wherein said at least two DAAs comprise: Compound 1 or a pharmaceutically acceptable salt thereof, and Compound 2 or a pharmaceutically acceptable salt thereof.
